My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 473

    1.

    Inflammation: a way to understanding the evolution of portal hypertension.

    Aller MA, Arias JL, Cruz A, Arias J.

    Theor Biol Med Model. 2007 Nov 13;4:44. Review.PMID: 17999758 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.

    Aller MA, Arias JL, Arias J.

    J Transl Med. 2007 Sep 24;5:44. Review.PMID: 17892556 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Evolutive phases of experimental prehepatic portal hypertension.

    Aller MA, Nava MP, Cuellar C, Chivato T, Arias JL, Sanchez-Patan F, de Vicente F, Alvarez E, Arias J.

    J Gastroenterol Hepatol. 2007 Jul;22(7):1127-33. Review.PMID: 17608859 [PubMed - indexed for MEDLINE]Related articles

    4.

    Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension.

    Alonso MJ, Aller MA, Corcuera MT, Nava MP, Gömez F, Angulo A, Arias J.

    Hepatogastroenterology. 2005 Mar-Apr;52(62):541-6.PMID: 15816474 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased duodenal mucosa infiltration by mast cells in rats with portal hypertension.

    Diez-Arias JA, Aller MA, Palma MD, Arias JL, Muñiz E, Sánchez M, Arias J.

    Dig Surg. 2001;18(1):34-40.PMID: 11244257 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome?

    Sánchez-Patán F, Anchuelo R, Aller MA, Vara E, García C, Nava MP, Arias J.

    Lipids Health Dis. 2008 Feb 13;7:4.PMID: 18271959 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Splanchnic remodeling secondary to experimental prehepatic portal hypertension]

    Corcuera Pindado MT, Nava Hidalgo MP, Angulo Burgos A, Aller Reyero MA, Gómez Aguado F, Casado Fariñas I, Alonso Martín MJ, Pérez AJ.

    An Med Interna. 2005 Jul;22(7):317-22. Spanish. PMID: 16288575 [PubMed - indexed for MEDLINE]Related articles

    8.

    Portal hypertension produces an evolutive hepato-intestinal pro- and anti-inflammatory response in the rat.

    Palma MD, Aller MA, Vara E, Nava MP, Garcia C, Arias-Diaz J, Balibrea JL, Arias J.

    Cytokine. 2005 Aug 7;31(3):213-26.PMID: 15950486 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.

    Sanchez-Patan F, Anchuelo R, Vara E, Garcia C, Saavedra Y, Vergara P, Cuellar C, Rodero M, Aller MA, Arias J.

    Hepatobiliary Pancreat Dis Int. 2008 Aug;7(4):383-94.PMID: 18693174 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Steatosis and portal hypertension.

    Puoti C, Bellis L.

    Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):285-90.PMID: 16231591 [PubMed - indexed for MEDLINE]Related articles

    11.

    Animal models of portal hypertension.

    Abraldes JG, Pasarín M, García-Pagán JC.

    World J Gastroenterol. 2006 Nov 7;12(41):6577-84. Review.PMID: 17075968 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat.

    Prieto I, Aller MA, Santamaría L, Nava MP, Madero R, Pérez-Robledo JP, Arias J.

    J Gastroenterol Hepatol. 2005 Jul;20(7):1025-31.PMID: 15955210 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats.

    Sánchez-Patán F, Aller MA, Cuellar C, Rodero M, Corcuera MT, Nava MP, Gómez F, Blanco MD, Guerrero S, Anchuelo R, Muñiz E, Alonso MJ, Teijón JM, Arias J.

    Exp Toxicol Pathol. 2008 Aug;60(4-5):347-55. Epub 2008 Jun 2.PMID: 18514499 [PubMed - indexed for MEDLINE]Related articles

    14.

    Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.

    Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M.

    Hepatology. 2009 Apr;49(4):1245-56.PMID: 19137587 [PubMed - indexed for MEDLINE]Related articles

    15.

    Portal hypertension.

    Garcia-Tsao G.

    Curr Opin Gastroenterol. 2006 May;22(3):254-62. Review.PMID: 16550040 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats.

    Prieto I, Jiménez F, Aller MA, Nava MP, Vara E, Garcia C, Arias J.

    World J Surg. 2005 Jul;29(7):903-8.PMID: 15951934 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Pathogenesis of portal hypertension]

    Montaño-Loza A, Meza-Junco J.

    Rev Invest Clin. 2005 Jul-Aug;57(4):596-607. Review. Spanish. PMID: 16315644 [PubMed - indexed for MEDLINE]Related articles

    18.

    Portal hypertension: from bedside to bench.

    Groszmann RJ, Abraldes JG.

    J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S125-30. Review.PMID: 15758647 [PubMed - indexed for MEDLINE]Related articles

    19.

    Management of portal hypertension and its complications.

    Jaffe DL, Chung RT, Friedman LS.

    Med Clin North Am. 1996 Sep;80(5):1021-34. Review.PMID: 8804373 [PubMed - indexed for MEDLINE]Related articles

    20.

    The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.

    Mejias M, Garcia-Pras E, Tiani C, Bosch J, Fernandez M.

    J Cell Mol Med. 2008 Sep-Oct;12(5A):1690-9. Epub 2008 Jan 11.PMID: 18194463 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk